| Financial Year |
March 31 2023 |
| Monetary Funds |
657,606,279.60 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,362,888.05 |
| Accounts Receivable |
1,329,508,507.68 |
| Advances to Suppliers |
721,927,042.86 |
| Other Receivables |
132,176,242.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,104,521,454.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,577,609.21 |
| Total Current Assets |
3,977,680,024.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
61,897,608.71 |
| Fixed Assetes |
887,276,863.23 |
| Under-construction Projects |
151,183,549.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
53,731,795.78 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,478,173,072.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
500,464,373.15 |
| Deferred Income Tax Assets |
3,552,742.32 |
| Other Non-Current Assets |
161,334,326.61 |
| Sub-Total of Non-Current Assets |
4,660,767,631.02 |
| Total Assets |
8,638,447,655.75 |
| Short-Term Loans |
2,076,989,238.74 |
| Trading Financial liabilities |
-- |
| Notes Payable |
145,420,948.20 |
| Accounts Payable |
147,374,712.70 |
| Accounts Received In Advance |
5,004,050.00 |
| Employee Compensation Payable |
32,849,115.00 |
| Taxes Payable |
48,827,607.77 |
| Interest Payable |
-- |
| Dividend Payable |
1,503,000.00 |
| Other payables |
372,861,235.98 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
358,045,610.96 |
| Other Current Liabilities |
5,849,220.43 |
| Sub-Total of Current Liabilities |
3,487,550,372.12 |
| Long-term Loans |
624,769,395.83 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
182,209,682.24 |
| Special Payable |
-- |
| Estimatied Liabilities |
12,751,944.81 |
| Deferred Income Tax Liabilities |
17,000,555.82 |
| Other Non-Current Liabilities |
858,641.53 |
| Sub-Total of Non-Current Liabilities |
1,045,597,921.34 |
| Total Liabilities |
4,533,148,293.46 |
| Paid-In Capital(Or Share Stock) |
1,946,915,121.00 |
| Capital Surplus |
470,321,087.63 |
| Surplus Reserve |
352,128,423.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,299,905,646.54 |
| Minority Stockholder's Interest |
-3,986,229.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,109,285,591.53 |
| Owner's Equity（Stockholder's Equity） |
4,105,299,362.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,638,447,655.75 |
